project id: TCGA-LUAD; case submitter id: TCGA-NJ-A55A; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; rna integrity number: 7.7; age at index: 76; days to birth: -28022; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1933; age at diagnosis: 28022; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 15.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8550/3; primary diagnosis: Acinar cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; is ffpe: false; composition: Not Reported; days to collection: 1199; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-NJ-A55A-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 3.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 40.0; percent stromal cells: 0.0; percent tumor cells: 60.0; percent tumor nuclei: 65.0;